equityflowunderstand the flow and follow it
EquityFlow › Companies › BIOPHTA

BIOPHTA

biotech · FR

Preclinical biotech developing non-invasive topical therapy for eye diseases.

Funding history

DateRoundAmount
Jun 2024Seed
BIOPHTA closed €6.5M in seed funding led by UI Investissement, Elaia and GO Capital to advance its ophthalmology technology toward clinical development.
$7M

Investors

Tap an investor to see what else they have backed.

ElaiaGO CapitalUI Investissement

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA

Other companies in FR

CardNexusMendoUncovrAlta AresInnovafeedInnovorderQuoblyMokNWandercraftArlequin AIKoletFungu'it

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.